BioHarvest Sciences Inc.: BioHarvest Sciences Announces a Private Placement of up to CAD $8M of Convertible Notes to Grow Core Business
Funds will also support the R&D program for potentially availing Active Pharmaceutical Ingredients (APIs) to the pharmaceutical industry with compositions based on its botanical synthesis technology2
Source: finanznachrichten.de